| YFV | Yellow fever virus |
| DENV | Dengue virus |
| CHIKV | Chikungunya virus |
| ZIKV | Zika virus |
| MAC | Membrane attack complex |
| hC3 | Human complement protein C3 |
| hC5a | Human complement protein C5a |
| AaMCR | Ae. aegypti macroglobulin complement-related proteins |
| AMP | Antimicrobial peptides |
| TBV | Transmission blocking vaccines |
| LVP_AGWG | Liverpool Aedes Genome Working Group |
| STAR | Spliced Transcripts Alignment to a Reference |
| RSEM | RNA-Seq by Expectation-Maximization |
| FDR | False discovery rate |
| CPM | Counts per Million |
| TMM | Trimmed Mean of M-values |
| DE | Differentially expressed |
| IB | Blood with heat-inactivated plasma |
| NB | Blood with normal plasma |
| SF | Sugar-fed |
| FC | Fold change |
| GSEA | Gene Set Enrichment Analysis |
| MF | Molecular functions |
| GO | Gene Ontology |
| IRT | Immune response transcripts |
| 5G1 | Late-phase trypsin |
| ACA | Anticomplementary activity |
| C5aR1 | C5a receptor 1 (CD88) |
| C5aR2 | C5a receptor 2 (C5L2) |
| GTP | Guanosine-5’-triphosphate |
| EDTA | Ethylenediaminetetraacetic acid |
| RBC | Red blood cells |
| PBS | Phosphate Buffered Saline |
| BME | Basal Medium Eagle |
| KOAPF | K-State Open Access Publishing Fund |